Correlation Between ATT and Endonovo Therapeutics

Can any of the company-specific risk be diversified away by investing in both ATT and Endonovo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and Endonovo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ATT Inc and Endonovo Therapeutics, you can compare the effects of market volatilities on ATT and Endonovo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of Endonovo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and Endonovo Therapeutics.

Diversification Opportunities for ATT and Endonovo Therapeutics

-0.67

Correlation Coefficient

ATT  Endonovo Therapeutics

Excellent diversification

The 3 months correlation between ATT and Endonovo is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and Endonovo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Endonovo Therapeutics and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with Endonovo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Endonovo Therapeutics has no effect on the direction of ATT i.e., ATT and Endonovo Therapeutics go up and down completely randomly.

Pair Corralation between ATT and Endonovo Therapeutics

Taking into account the 90-day investment horizon ATT Inc is expected to generate 0.12 times more return on investment than Endonovo Therapeutics. However, ATT Inc is 8.17 times less risky than Endonovo Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Endonovo Therapeutics is currently generating about -0.04 per unit of risk. If you would invest  2,017  in ATT Inc on September 3, 2024 and sell it today you would earn a total of  299.00  from holding ATT Inc or generate 14.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ATT Inc  vs.  Endonovo Therapeutics

ATT Inc

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in ATT Inc are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, ATT unveiled solid returns over the last few months and may actually be approaching a breakup point.

Endonovo Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Endonovo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with ATT and Endonovo Therapeutics

The main advantage of trading using opposite ATT and Endonovo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, Endonovo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endonovo Therapeutics will offset losses from the drop in Endonovo Therapeutics' long position.

The idea behind ATT Inc and Endonovo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.